Application of edetate in properly changing surface tension of tiotropium bromide olodaterol spray
Patent Information
- Authority / Receiving Office
- CN · China
- Patent Type
- Applications(China)
- Current Assignee / Owner
- TIANJIN JINYAO GRP
- Publication Date
- 2020-03-13
Smart Images

Figure 1 
Figure 2 
Figure 3
Abstract
Description
Technical field:
[0001] The present invention relates to the drug tiotropium bromide olodaterol spray for treating respiratory diseases, especially asthma, chronic obstructive pneumonia, bronchitis, etc., wherein edetate is changed from tiotropium bromide or its Hydrate, olodaterol pharmaceutical salts, and the application of the surface tension of the pharmaceutical composition composed of water. Background technique:
[0002] Asthma is a chronic airway inflammation characterized by reversible airway obstruction and increased airway responsiveness. Airway obstruction is caused by two factors: increased secretions caused by bronchial mucosal inflammation, mucosal edema, and smooth muscle spasm stimulated by inflammation; while asthma Increased airway reactivity is also a result of damage to the bronchial epithelium due to airway inflammation. It is recognized that only by controlling the inflammation of the airway mucosa can the ultimate goal of reducing airway hyperrespons...